HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alfred Zippelius Selected Research

Lectins

3/2024Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2.
10/2020Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alfred Zippelius Research Topics

Disease

90Neoplasms (Cancer)
03/2024 - 01/2002
28Melanoma (Melanoma, Malignant)
04/2024 - 07/2002
18Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2013
7Breast Neoplasms (Breast Cancer)
01/2023 - 03/2004
7Neoplasm Metastasis (Metastasis)
01/2021 - 04/2004
5Lung Neoplasms (Lung Cancer)
03/2024 - 01/2015
5Pneumonia (Pneumonitis)
01/2024 - 12/2015
3Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 01/2015
3Disease Progression
11/2022 - 10/2014
2Myocarditis (Carditis)
01/2024 - 01/2015
2Hodgkin Disease (Hodgkin's Disease)
01/2023 - 11/2019
2Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 11/2018
2Tertiary Lymphoid Structures
01/2021 - 01/2018
2Carcinogenesis
10/2020 - 10/2019
2Colorectal Neoplasms (Colorectal Cancer)
11/2019 - 10/2019
2Virus Diseases (Viral Diseases)
01/2018 - 01/2017
2Adenocarcinoma
01/2017 - 05/2016
2Inflammation (Inflammations)
01/2016 - 11/2015
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2015 - 01/2013
1Infections
05/2024
1Hepatitis
01/2024
1Colitis
01/2024
1Diabetes Mellitus
01/2023
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
01/2023
1Optic Nerve Diseases (Optic Neuropathy)
01/2023

Drug/Important Bio-Agent (IBA)

17AntigensIBA
05/2024 - 01/2002
17Immune Checkpoint InhibitorsIBA
01/2024 - 01/2016
12AntibodiesIBA
01/2022 - 10/2002
10Peptides (Polypeptides)IBA
12/2018 - 07/2002
9Proteins (Proteins, Gene)FDA Link
03/2021 - 09/2004
8LigandsIBA
11/2022 - 10/2010
8MART-1 AntigenIBA
10/2010 - 07/2002
7IpilimumabIBA
02/2024 - 01/2015
7Neoplasm Antigens (Tumor Antigens)IBA
12/2019 - 10/2002
6NivolumabIBA
01/2023 - 01/2015
6CytokinesIBA
09/2022 - 02/2016
6Messenger RNA (mRNA)IBA
12/2019 - 06/2007
6VaccinesIBA
01/2018 - 01/2002
5Sialic Acid Binding Immunoglobulin-like LectinsIBA
03/2024 - 11/2018
5Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2020
4pembrolizumabIBA
01/2023 - 01/2015
4Immunoconjugates (Immunoconjugate)IBA
10/2019 - 08/2014
3N-Acetylneuraminic Acid (Sialic Acid)IBA
03/2024 - 10/2020
3Polysaccharides (Glycans)IBA
03/2024 - 10/2020
3Bispecific AntibodiesIBA
11/2022 - 02/2016
3Programmed Cell Death 1 ReceptorIBA
11/2022 - 01/2016
3RNA (Ribonucleic Acid)IBA
11/2022 - 12/2018
3Interleukin-12 (IL 12)IBA
09/2022 - 12/2018
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 09/2015
3EpitopesIBA
03/2009 - 07/2002
3Differentiation AntigensIBA
02/2007 - 04/2004
2LectinsIBA
03/2024 - 10/2020
2Immunoglobulins (Immunoglobulin)IBA
03/2024 - 11/2022
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2024 - 01/2015
2Infliximab (Remicade)FDA Link
01/2024 - 01/2018
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2024 - 01/2023
2Dinoprostone (PGE2)FDA Link
01/2023 - 01/2023
2AutoantibodiesIBA
01/2023 - 01/2017
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2022 - 01/2019
2Cisplatin (Platino)FDA LinkGeneric
10/2021 - 09/2015
2Interleukin-2 (IL2)IBA
03/2021 - 10/2010
2InterferonsIBA
01/2021 - 01/2019
2AutoantigensIBA
01/2021 - 05/2003
2Antisense OligonucleotidesIBA
01/2020 - 12/2019
2Blocking AntibodiesIBA
11/2019 - 03/2015
2Monoclonal AntibodiesIBA
08/2019 - 11/2018
2carbonic anhydrase XIIIBA
08/2019 - 12/2015
2SurvivinIBA
05/2019 - 01/2019
2Uncoupling Protein 2IBA
04/2019 - 01/2019
2Ado-Trastuzumab EmtansineIBA
01/2019 - 11/2015
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 09/2017
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2018 - 04/2004
2PlatinumIBA
01/2018 - 01/2017
2Pemetrexed (MTA)FDA Link
01/2017 - 09/2015
2Bevacizumab (Avastin)FDA Link
01/2017 - 09/2015
2Drug CombinationsIBA
01/2016 - 09/2015
2VemurafenibIBA
01/2015 - 05/2013
2HLA-A2 Antigen (HLA A2 Antigen)IBA
10/2010 - 05/2004
2HLA-A*02:01 antigenIBA
12/2006 - 02/2003
1Sialic AcidsIBA
03/2024
1Abatacept (Orencia)FDA Link
01/2024
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2024
1vedolizumabIBA
01/2024
1ruxolitinibIBA
01/2024
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2024
1Acetylcysteine (Siran)FDA LinkGeneric
01/2023
1pegademase bovine (pegADA)FDA Link
01/2023
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2023
1cyclopropapyrroloindoleIBA
01/2023
1SteroidsIBA
01/2023
1AlpelisibIBA
01/2023
1Chimeric Antigen ReceptorsIBA
01/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023
1ProstaglandinsIBA
01/2023

Therapy/Procedure

38Immunotherapy
02/2024 - 01/2002
33Therapeutics
01/2024 - 08/2003
7Drug Therapy (Chemotherapy)
10/2021 - 01/2013
6Radiotherapy
01/2019 - 01/2014
3Neoadjuvant Therapy
10/2021 - 09/2015
1Cell- and Tissue-Based Therapy (Cell Therapy)
04/2024